Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors-Reference-Cited by-同舟云学术

Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors

Published:2013-11 Issue: Volume:59 Page:141-150
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Mecha M.,Feliú A.,Iñigo P.M.,Mestre L.,Carrillo-Salinas F.J.,Guaza C.

Funder

Ministry of Economy and Competitiveness

Instituto de Salud Carlos III

Red Española de Esclerosis Múltiple

Publisher

Elsevier BV

Subject

Neurology

Reference59 articles.

1. The role of integrins in immune-mediated diseases of the nervous system;Archelos;Trends Neurosci.,1999

2. Therapeutic action of cannabinoids in a murine model of multiple sclerosis;Arevalo-Martin;J. Neurosci.,2003

3. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide;Bisogno;Br. J. Pharmacol.,2001

4. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species;Brosnan;Neurology,1995

5. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression;Carrier;Proc. Natl. Acad. Sci. U. S. A.,2006

Cited by 225 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunologic analysis of CSF in patients with de novo diagnosed RRMS. The role of chemokines in the early phase of the disease;Multiple Sclerosis and Related Disorders;2024-10

2. Emerging roles of cannabinoid receptor CB2 receptor in the central nervous system: therapeutic target for CNS disorders;Psychopharmacology;2024-09-12

3. Molecular Interactions Underlying Dissolution Trends in Cannabidiol-Polymer Amorphous Solid Dispersions;Macromolecules;2024-08-20

4. Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects;Biomedicine & Pharmacotherapy;2024-07

5. Oxytocin and Vasopressin Gene Expression in the Brain as Potential Biomarkers for Cannabidiol Therapeutic Efficacy;Biomedicines;2024-06-07